The fundraiser includes $20 million in new funds to help the company grow in the USA
Digital health and wellness start-up Healthify (formerly Healthily) has closed its $45 million round. It was led by existing investors Khosla Ventures and LeapFrog Investments. Further, the round also saw participation from Claypond Capital (the family office of Indian healthcare billionaire Ranjan Pai).
The funding comes at a time when the healthcare start-up is focusing on global expansion. The start-up aims to enter the USA market and advance its industry-leading AI capabilities. The fundraiser includes $20 million in new funds to help the company grow in the USA. The new $20 million adds to an earlier tranche raised in 2023, bringing Healthify's total primary equity raise to approximately $125 million to date, as per the company.
“After delivering outcomes at scale in India with our unique blend of AI and human coaching, we’re thrilled to bring this approach to the US, the world’s largest health and fitness market. With this funding, we’re one step closer to achieving our mission of putting a high-acuity health coach in every person’s pocket,” said Tushar Vashisht, co-founder and CEO, Healthify, in a statement.
The company claims that it has a 40 million strong user base in India. Further, Healthify has conducted alpha tests in the US, which sets the stage for a full launch in the coming months, the company said in a statement.
“Healthify has been pioneering the use of AI since 2017 and continues to lead the field in leveraging AI to amplify the impact of its coaches and create better health outcomes for its users. We are thrilled to back the company in this round, to seize the potential of newer and more powerful AI models, which can supercharge their growth and bring them closer to their ambition of touching a billion lives,” said Biju Mohandas of LeapFrog Investments.
The company pioneered the use of AI alongside human coaches to drive outcomes in behavior change and weight loss, achieving some of the highest outcome-to-cost ratios globally.
With regards to its financials, the company claims that it is on track to become EBITDA-positive by the end of the fiscal year. Along with consumer business, the digital health and wellness start-up has a B2B strategy to drive growth. It focuses on corporate wellness partnerships and also collaborations with diagnostics and pharmaceutical firms.